Dr Jim Ross, who comes from Kilmarnock, has been awarded a grant from the Association for International Cancer Research (AICR) to investigate the role of Proteolysis Inducing Factor - or PIF - in prostate cancer spread following the discovery by US scientists of a link with advanced breast cancer.
Dr Ross of the Tissue Injury and Repair Group at the University of Edinburgh’s Medical School explains: "Over half of all patients with advanced prostate cancer will develop cancer cachexia which is the name of the syndrome of weight loss, loss of appetite and anaemia associated with advanced malignancy.”
"The weight loss of cancer cachexia is associated with a lower survival rate and poorer response to chemotherapy and radiotherapy. And, with even a five per cent weight loss it leads to a worse prognosis than for a cancer patient of normal weight."
Recently, scientists have discovered that starving cancer cells of oxygen will cause many tumour cells to perish. However, paradoxically, the hardiest of prostate cancer cells will survive these harsh conditions and flourish. It is now thought that low oxygen levels allow the selection of prostate cancer cells which become more aggressive and eventually lead to spread of the cancer to other sites, rendering the disease incurable.
Adds Dr Ross: " PIF has also been identified as permitting survival of breast cancer cells when they are grown in the low oxygen conditions present in a tumour and may allow these cancer cells to survive, divide and spread. Breast cancers not able to produce PIF are less likely to be able to survive these conditions and are less aggressive. Recently, PIF has also been found in some prostate cancers and our study will investigate its role in allowing the survival of prostate cancer cells in an oxygen-reduced environment."
According to Dr Mark Matfield, AICR's scientific adviser if PIF is found to support survival of prostate cancer cells then it would be a good target for future treatment of a cancer which currently claims the lives of more than 10,000 UK men every year.
"Dr Ross and his colleagues, Professor Kenneth Fearon and Drs Grant Stewart and Fouad Habib, will study improved methods of detecting PIF in cells and bodily secretions such as urine. The hope is to be able to produce a new detection method and to target these patients with novel drugs to treat weight-loss associated with cancer."
Derek Napier, AICR's Chief Executive says the three-year grant, worth more than £100,000, has been given in line with the charity's policy of funding the most novel approaches to research worldwide. “This is an exciting project set to tackle one of the most challenging problems facing cancer researchers. However, these are early days and it could be some time before it is known whether it will lead to effective drugs to help treat cancer patients,” he cautions.
Susan Osborne | alfa
The cytoskeleton of neurons has been found to be involved in Alzheimer's disease
18.01.2019 | University of the Basque Country
Bioinspired nanoscale drug delivery method developed by WSU, PNNL researchers
10.01.2019 | Washington State University
The scientific and political community alike stress the importance of German Antarctic research
Joint Press Release from the BMBF and AWI
The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...
World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles
The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.
Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.
In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...
Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.
It all starts with an ear. Empa researcher Michael Hausmann removes the object shaped like a human ear from the 3D printer and explains:
The phenomenon of so-called superlubricity is known, but so far the explanation at the atomic level has been missing: for example, how does extremely low friction occur in bearings? Researchers from the Fraunhofer Institutes IWM and IWS jointly deciphered a universal mechanism of superlubricity for certain diamond-like carbon layers in combination with organic lubricants. Based on this knowledge, it is now possible to formulate design rules for supra lubricating layer-lubricant combinations. The results are presented in an article in Nature Communications, volume 10.
One of the most important prerequisites for sustainable and environmentally friendly mobility is minimizing friction. Research and industry have been dedicated...
16.01.2019 | Event News
14.01.2019 | Event News
12.12.2018 | Event News
18.01.2019 | Materials Sciences
18.01.2019 | Life Sciences
18.01.2019 | Health and Medicine